Covered recipient · General Payments record
DIANE MCKEEFF
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$1,293.30
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $606.36 | 27 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $283.82 | 11 |
| PFIZER INC. | $66.27 | 3 |
| Lilly USA, LLC | $60.35 | 3 |
| Novo Nordisk AS | $59.44 | 3 |
| Exact Sciences Corporation | $43.83 | 2 |
| Vanda Pharmaceuticals Inc. | $29.58 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.13 | 1 |
| Acerta Pharma LLC | $23.87 | 1 |
| Lundbeck LLC | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.08 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151125 | CMS |
| ABBVIE INC. | $22.33 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151129 | CMS |
| ABBVIE INC. | $22.98 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151135 | CMS |
| ABBVIE INC. | $16.44 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151139 | CMS |
| ABBVIE INC. | $21.13 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151145 | CMS |
| ABBVIE INC. | $68.08 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151149 | CMS |
| ABBVIE INC. | $26.72 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151153 | CMS |
| ABBVIE INC. | $25.36 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151159 | CMS |
| ABBVIE INC. | $23.42 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151161 | CMS |
| ABBVIE INC. | $17.24 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151167 | CMS |
| ABBVIE INC. | $7.04 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006151173 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.87 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011252547 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.13 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996849017 | CMS |
| Exact Sciences Corporation | $20.74 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026773201 | CMS |
| Exact Sciences Corporation | $23.09 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026773229 | CMS |
| Lilly USA, LLC | $19.50 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032808637 | CMS |
| Lilly USA, LLC | $19.41 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032808639 | CMS |
| Lilly USA, LLC | $21.44 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032878821 | CMS |
| Lundbeck LLC | $15.07 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032619687 | CMS |
| Novo Nordisk Inc | $16.84 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002690785 | CMS |
| Novo Nordisk Inc | $18.75 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002690797 | CMS |
| Novo Nordisk Inc | $23.85 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002690807 | CMS |
| PFIZER INC. | $25.55 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049593597 | CMS |
| PFIZER INC. | $21.10 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050162057 | CMS |
| PFIZER INC. | $19.62 | 12/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050182117 | CMS |
| Vanda Pharmaceuticals Inc. | $16.23 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051569243 | CMS |
| Vanda Pharmaceuticals Inc. | $13.35 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051569245 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.